https://doi.org/10.4081/monaldi.2023.2667
Differences in nutritional status of patients with chronic obstructive pulmonary disease between Mediterranean and non-Mediterranean regions in Croatia
Submitted: June 16, 2023
Accepted: August 29, 2023
Published: September 13, 2023
Accepted: August 29, 2023
Abstract Views: 576
PDF_early view: 334
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The nutritional status of patients with chronic obstructive pulmonary disease (COPD) is a significant factor that influences the prognosis of the disease. This observational study aimed to analyse the nutritional status of COPD patients and assess the associations between nutritional status, disease severity, and exercise capacity in four different regions of Croatia. In this multicentre study, 534 COPD patients were recruited and evaluated concerning fat-free mass (FFM), fat-free mass index (FFMI), skeletal muscle mass index (SMMI), phase angle (PhA), pulmonary function tests, and the 6-minute walk test (6MWT). There were 325 (60.9%) male and 209 (39.1%) female patients with a mean age of 66.7±8.4 years. Most patients (73.2%) exhibited a moderate to severely abnormal obstructive pattern and had a reduced 6MWT distance (396.5±110.8 m). Among the participants, 32.8% were overweight and 22.3% were obese, and they had satisfactory values for nutritional status variables (FFM, FFMI, SMMI, PhA). There were no statistical differences between the centres in terms of nutritional status variables. There was a significantly positive correlation of FEV1 with BMI (r=0.148, p=0.001), PhA (r=0.256, p=0.00), FFM (r=0.365, p=0.00), and SMMI (r=0.238, p=0.00). However, there was no significant correlation of the 6MWT with BMI (r=-0.049, p=0.254), FFM (r=0.065, p=0.133), and SMMI (r=-0.007, p=0.867). The data analysis demonstrated that our patients were not underweight and that there was no significant difference between the centres in terms of BMI, FFM, FFMI, SMMI, and PhA. This lack of significant difference was observed even though one of the regions studied was Mediterranean.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for prevention, diagnosis and management of COPD: Report 2023.[Accessed March 6, 2023. Available from: https://goldcopd.org/2023-gold-report-2/
Halpin DMG, Celli BR, Criner GJ, et al. The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries. Int J Tuberc Lung Dis 2019;23:1131-41.
DOI: https://doi.org/10.5588/ijtld.19.0397
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3: e442.
DOI: https://doi.org/10.1371/journal.pmed.0030442
Eisner MD, Blanc PD, Sidney S, et al. Body composition and functional limitation in COPD. Respir Res 2007;8:7.
DOI: https://doi.org/10.1186/1465-9921-8-7
Laviolette L, Sava F, O'Donnell DE, et al. Effect of obesity on constant work rate exercise in hyperinflated men with COPD. BMC Pulm Med 2010;10:33.
DOI: https://doi.org/10.1186/1471-2466-10-33
O'Donnell DE, Deesomchok A, Lam YM, et al. Effects of BMI on static lung volumes in patients with airway obstruction. Chest 2011;140:461-8.
DOI: https://doi.org/10.1378/chest.10-2582
Vozoris NT, O'Donnell DE. Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. Can Respir J 2012;19:e18-24.
DOI: https://doi.org/10.1155/2012/732618
White JV, Guenter P, Jensen G, et al. Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). JPEN J Parenter Enteral Nutr 2012;36:275-83.
DOI: https://doi.org/10.1177/0148607112440285
Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006;173:79-83.
DOI: https://doi.org/10.1164/rccm.200506-969OC
Raad S, Smith C, Allen K. Nutrition status and chronic obstructive pulmonary disease: can we move beyond the body mass index? Nutr Clin Pract 2019;34:330-9.
DOI: https://doi.org/10.1002/ncp.10306
De Blasio F, Scalfi L, Di Gregorio A, et al. Raw bioelectrical impedance analysis variables are independent predictors of early all-cause mortality in patients with COPD. Chest 2019;155:1148-57.
DOI: https://doi.org/10.1016/j.chest.2019.01.001
Luo Y, Zhou L, Li Y, et al. Fat-free mass index for evaluating the nutritional status and disease severity in COPD. Respir Care 2016;61:680-8.
DOI: https://doi.org/10.4187/respcare.04358
Nguyen HT, Collins PF, Pavey TG, et al. Nutritional status, dietary intake, and health-related quality of life in outpatients with COPD. Int J Chron Obstruct Pulmon Dis 2019;14:215-26.
DOI: https://doi.org/10.2147/COPD.S181322
Mete B, Pehlivan E, Gülbaş G, Günen H. Prevalence of malnutrition in COPD and its relationship with the parameters related to disease severity. Int J Chron Obstruct Pulmon Dis 2018;13:3307-12.
DOI: https://doi.org/10.2147/COPD.S179609
Trichopoulou A, Kouris-Blazos A, Wahlqvist ML, et al. Diet and overall survival in elderly people. BMJ 1995;311:1457-60.
DOI: https://doi.org/10.1136/bmj.311.7018.1457
Fischer A, Johansson I, Blomberg A, Sundström B. Adherence to a Mediterranean-like diet as a protective factor against COPD: A nested case-control study. COPD 2019;16:272-7.
DOI: https://doi.org/10.1080/15412555.2019.1634039
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
DOI: https://doi.org/10.1164/ajrccm.166.1.at1102
Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 2004;23:1430-53.
DOI: https://doi.org/10.1016/j.clnu.2004.09.012
NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet 2016;387:1377-96.
DOI: https://doi.org/10.1016/S0140-6736(16)30054-X
Medanić D, Pucarin-Cvetković J. [Pretilost – Javnozdravstveni Problem I Izazov - Obesity - Public health problem and challenge].[Article in Croatian]. Acta Medica Croat 2012;66:347-54.
Maslarda D, Bressan L. [Poremećaj u prehrani – pretilost: prehrambene navike, tjelesna aktivnosti i samoprocjena BMI u Hrvatskoj - Eating disorder - obesity: eating habits, physical activity and self-reported BMI in Croatia].[Article in Croatian]. J Appl Health Sci 2020;6:83-90.
DOI: https://doi.org/10.24141/1/6/1/9
Bhatta L, Leivseth L, Mai XM et al. GOLD classifications, COPD hospitalization, and all-cause mortality in chronic obstructive pulmonary disease: The HUNT study. Int J Chron Obstruct Pulmon Dis 2020;15:225-33.
DOI: https://doi.org/10.2147/COPD.S228958
Kahnert K, Alter P, Young D, et al. The revised GOLD 2017 COPD categorization in relation to comorbidities. Respir Med 2018;134:79-85.
DOI: https://doi.org/10.1016/j.rmed.2017.12.003
Le LAK, Johannessen A, Hardie JA, et al. Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort. Int J Chron Obstruct Pulmon Dis 2019;14:1639-55.
DOI: https://doi.org/10.2147/COPD.S194019
Varmaghani M, Dehghani M, Heidari E, et al. Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. East Mediterr Health J 2019;25:47-57.
DOI: https://doi.org/10.26719/emhj.18.014
Putcha N, Drummond MB, Wise RA, Hansel NN. Comorbidities and chronic obstructive pulmonary disease: prevalence, influence on outcomes, and management. Semin Respir Crit Care Med 2015;36:575-91.
DOI: https://doi.org/10.1055/s-0035-1556063
Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis 2014;9:871-88.
DOI: https://doi.org/10.2147/COPD.S49621
Cavaillès A, Brinchault-Rabin G, Dixmier A, et al. Comorbidities of COPD. Eur Respir Rev 2013;22:454-75.
DOI: https://doi.org/10.1183/09059180.00008612
Sabino PG, Silva BM, Brunetto AF. Nutritional status is related to fat-free mass, exercise capacity and inspiratory strength in severe chronic obstructive pulmonary disease patients. Clinics (Sao Paulo) 2010;65:599-605.
DOI: https://doi.org/10.1590/S1807-59322010000600007
James BD, Jones AV, Trethewey RE, Evans RA. Obesity and metabolic syndrome in COPD: Is exercise the answer? Chron Respir Dis 2018;15:173-181.
DOI: https://doi.org/10.1177/1479972317736294
Vrbica Ž, Vukić Dugac A, Popović Grle S, et al. [Smjernice Guidelines Preporuke za prevenciju i liječenje u bolesnika s kroničnom opstruktivnom plućnom bolesti - Recommendations for prevention and treatment of malnutrition in patients with chronic obstructive pulmonary disease].[Article in Croatian]. Liječnički Vjesnik 2018;140:183-9.
DOI: https://doi.org/10.26800/LV-140-7-8-24
How to Cite
Muršić, Davorka, Tajana Jalušić Glunčić, Jelena Ostojić, Sanda Škrinjarić Cincar, Ljiljana Bulat Kardum, Martina Dokoza, Nataša Karamarković Lazarušić, Erim Bešić, Miroslav Samaržija, and Andrea Vukić Dugac. 2023. “Differences in Nutritional Status of Patients With Chronic Obstructive Pulmonary Disease Between Mediterranean and Non-Mediterranean Regions in Croatia”. Monaldi Archives for Chest Disease, September. https://doi.org/10.4081/monaldi.2023.2667.
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Luigi Pinto, Pietro Schino, Michele Bitetto, Ersilia Tedeschi, Michele Maiellari, Giancarlo De Leo, Elena Ludovico, Giovanni Larizza, Franco Mastroianni, Fibrotic outcomes from SARS-CoV-2 virus interstitial pneumonia , Monaldi Archives for Chest Disease: Early Access
- Matteo Monami, Sara Aleffi, Hyperglycemia, hypoglycemia and glycemic variability in the elderly: a fatal triad? , Monaldi Archives for Chest Disease: Vol. 84 No. 1-2 (2015): Cardiac series
- Rafael Martínez-Girón, Liron Pantanowitz, Pulmonary actinomycosis: cytomorphological features , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Michele Correale, Agostino Lopizzo, Francesco Santoro, Antonio Ruggero, Andrea Cuculo, Riccardo Leva, Matteo Di Biase, Acute heart failure in an adult with unrecognized congenital heart disease , Monaldi Archives for Chest Disease: Vol. 76 No. 3 (2011): Cardiac series
- Cuneyt Tetikkurt, Buket Caliskaner Ozturk, Nejdiye Gungordu, Diagnosis of pleuroparenchymal fibroelastosis: A review , Monaldi Archives for Chest Disease: Vol. 93 No. 3 (2023)
- Barbara Piovanelli, Riccardo Rovetta, Ivano Bonadei, Enrico Vizzardi, Antonio D’Aloia, Marco Metra, Nonbacterial Thrombotic Endocarditis in Pancreatic Cancer , Monaldi Archives for Chest Disease: Vol. 80 No. 4 (2013): Cardiac Series
- Benhur Joel Shadrach, Rishabh Goel, Kunal Deokar, Anukool Jain, Invasive pulmonary aspergillosis in a COVID-19 recovered patient: unravelling an infective sequalae of the SARS-CoV-2 virus , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
- Andrea Palomba, Francesco Pelizzo, Mattia Canevari, Olga Vriz, Pulmonary edema in a young male with severe uncontrolled cardiovascular risk factors and pan-vascular atherosclerosis: a case report , Monaldi Archives for Chest Disease: Early Access
- Vasiliki Epameinondas Georgakopoulou, Nikolaos Garmpis, Dimitrios Mermigkis, Christos Damaskos, Serafeim Chlapoutakis, Konstantinos Mantzouranis, Aikaterini Gkoufa, Chrysovalantis Papageorgiou, Anna Garmpi, Sotiria Makrodimitri, Evangelos Diamantis, Pagona Sklapani, Nikolaos Trakas, Xanthi Tsiafaki, Pulmonary adverse events due to immune checkpoint inhibitors: A literature review , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Riccardo Raddino, Debora Robba, Giorgio Caretta, Ivano Bonadei, Melissa Teli, Gregoriana Zanini, Alberto Madureri, Enrico Vizzardi, Livio Dei Cas, Erythropoietin: a new perspective in cardiovascular therapy , Monaldi Archives for Chest Disease: Vol. 70 No. 4 (2008): Cardiac series
<< < 34 35 36 37 38 39 40 41 42 43 > >>
You may also start an advanced similarity search for this article.
